In cancer cell lines, methylation of the Ripk3 promoter region inhibits the induction of Ripk3 gene expression, which is restored by the demethylating agent 5-aza-2′-deoxycytidine (5-AD)26. This evidence concerns the gene RIPK3 and cancer.